May 29 (Reuters) - Kalytera Therapeutics Inc KLY.V :
* KALYTERA ANNOUNCES DATA DEMONSTRATING THAT R-107 PRESERVES ORGAN FUNCTION IN A MURINE STUDY MIMICKING COVID-19 LUNG DISEASE
* KALYTERA - PLANS TO SUBMIT IND TO AUSTRALIAN THERAPEUTIC GOODS ADMINISTRATION & U.S FDA FOR CLINICAL STUDY OF R-107 IN PATIENTS WITH COVID-19 ASSOCIATED PNEUMONIA